Adashi E Y, Resnick C E, Jastorff B
Department of Obstetrics/Gynecology, University of Maryland School of Medicine, Baltimore 21201.
Mol Cell Endocrinol. 1990 Jul 30;72(1):1-11. doi: 10.1016/0303-7207(90)90234-y.
The intermediary role and relative importance of cAMP in follicle-stimulating hormone (FSH) hormonal action were reinvestigated at the level of the rat granulosa cell employing Rp-cAMPS, a novel antagonistic analog of cAMP. This approach may not only provide for direct documentation of cAMP dependence, but may also, by inference, highlight the potential relative importance of other putative intracellular second messenger systems. Initial cell-free validation studies indicated that Rp-cAMPS is capable of effectively competing with cAMP for binding to and activation of the regulatory subunit of the granulosa cell A-kinase holoenzyme. Subsequent whole-cell studies employed cultured rat granulosa cells, the cAMP-phosphodiesterase activity of which was suppressed with ZK62711. Basal progesterone accumulation was relatively low, remaining unaffected by treatment with a maximally effective dose of Rp-cAMPS by itself (10(-3) M). Whereas treatment with FSH (30 ng/ml) resulted in a substantial increase in progesterone accumulation, concurrent treatment with increasing concentrations (10(-6)-10(-3) M) or Rp-cAMPS brought about dose-dependent decrements in the FSH effect with a median effective dose of 1.8 +/- (SE) 0.4 x 10(-5) M and a maximal, but incomplete inhibitory effect of 70 +/- (SE) 6%. Higher concentrations of FSH (greater than or equal to 100 ng/ml) progressively diminished, but did not abolish the Rp-cAMPS blockade. Removal of Rp-cAMPS resulted in progressive resumption of FSH responsiveness suggesting reversibility of action. Significantly, Rp-cAMPS proved highly effective in blocking the action of its agonistic diastereomer Sp-cAMPS. However, Rp-cAMPS was unable to block the action of the lactogenic receptor agonist prolactin, the second messenger of which remains uncertain. Taken together, these findings provide additional direct support to the notion that cAMP may be an intracellular second messenger of FSH. However, to the extent that Rp-cAMPS is incapable of complete neutralization of FSH action, our findings further suggest that cAMP may play a central, albeit non-exclusive role in FSH-supported granulosa cell differentiation and that other putative second messenger systems may also be at play.
运用新型环磷酸腺苷(cAMP)拮抗类似物Rp-cAMPS,在大鼠颗粒细胞水平上对cAMP在促卵泡激素(FSH)激素作用中的中介作用及相对重要性进行了重新研究。这种方法不仅可以直接证明对cAMP的依赖性,还可以通过推理突出其他假定的细胞内第二信使系统的潜在相对重要性。最初的无细胞验证研究表明,Rp-cAMPS能够有效地与cAMP竞争,结合并激活颗粒细胞A激酶全酶的调节亚基。随后的全细胞研究使用了培养的大鼠颗粒细胞,其cAMP磷酸二酯酶活性用ZK62711进行了抑制。基础孕酮积累相对较低,单独用最大有效剂量的Rp-cAMPS(10⁻³M)处理时不受影响。而用FSH(30 ng/ml)处理导致孕酮积累大幅增加,同时用浓度递增(10⁻⁶ - 10⁻³M)的Rp-cAMPS处理会使FSH效应产生剂量依赖性降低,中位有效剂量为1.8±(标准误)0.4×10⁻⁵M,最大但不完全抑制效应为70±(标准误)6%。更高浓度的FSH(大于或等于100 ng/ml)会逐渐减弱,但不会消除Rp-cAMPS的阻断作用。去除Rp-cAMPS会导致FSH反应性逐渐恢复,表明作用具有可逆性。值得注意的是,Rp-cAMPS被证明能非常有效地阻断其激动性非对映体Sp-cAMPS的作用。然而,Rp-cAMPS无法阻断催乳素受体激动剂催乳素的作用,其第二信使尚不确定。综上所述,这些发现为cAMP可能是FSH的细胞内第二信使这一观点提供了额外的直接支持。然而,就Rp-cAMPS无法完全中和FSH作用而言,我们的发现进一步表明,cAMP可能在FSH支持的颗粒细胞分化中起核心作用,尽管并非唯一作用,其他假定的第二信使系统可能也在发挥作用。